CMS Finalizes Guidance for Third Round of Medicare Drug Price Negotiations
- October 03, 2025
The Centers for Medicare & Medicaid Services (CMS) released September 30 final guidance for the third round of Medicare drug price negotiations that focuses on improving the program’s transparency and implementing expanded protections for orphan drugs.
ARTICLE TAGS
You must be logged in to access this content.